Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid

Protoporphyrin IX‐fluorescence measurement is a powerful in situ approach for cancer detection after oral/topical administration of 5‐aminolevulinic acid. However, this approach has not been clinically established for breast cancer, probably due to insufficient delivery of 5‐aminolevulinic acid to t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Morita, Midori, Tanaka, Hideo, Kumamoto, Yasuaki, Nakamura, Akihiro, Harada, Yoshinori, Ogata, Takehiro, Sakaguchi, Koichi, Taguchi, Tetsuya, Takamatsu, Tetsuro
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746108/
https://ncbi.nlm.nih.gov/pubmed/31385432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2466
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi